Literature DB >> 11352368

The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being.

L Degenhardt1, W Hall.   

Abstract

BACKGROUND: The present paper aimed to: (a) provide Australian estimates of the population-level association between psychotic 'caseness' and substance use; (b) examine liability to problematical substance use according to 'caseness' via the conditional prevalence (prevalence among users); and (c) examine associations between problematical substance use and the number of psychotic symptoms using ordinal logistic regression.
METHOD: Data were from the National Survey of Mental Health and Well-Being (NSMHWB), a stratified multi-stage probability sample of Australian adults, using a subset of persons under the age of 50 years (N = 6722). A screener assessed the presence of characteristic psychotic symptoms. Associations between 'case' status and DSM-IV alcohol, cannabis and other drug use disorders were examined. Ordinal logistic regressions predicting psychosis scores were carried out, including demographic, mental health and drug use variables.
RESULTS: Ninety-nine persons (1.2%) screened positively for psychosis. Regular tobacco, alcohol and cannabis use were much more common among persons screening positively, as were alcohol, cannabis and other drug use disorders. Among alcohol and cannabis users, psychosis 'cases' were much more likely to be dependent. Ordinal logistic regressions revealed that regular tobacco use, cannabis and alcohol dependence, and opiate abuse were predictors of psychosis scores.
CONCLUSIONS: The mental health risks of problematical substance use need to be disseminated to persons at risk of, or suffering from, psychotic illness, and to heavy substance users. Work is needed to develop effective treatment approaches for problematical substance use among persons with psychosis.

Entities:  

Mesh:

Year:  2001        PMID: 11352368     DOI: 10.1017/s0033291701003865

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  25 in total

Review 1.  Cannabis and psychosis.

Authors:  Louisa Degenhardt; Wayne Hall
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

2.  Neurocognitive functioning of individuals with schizophrenia: using and not using drugs.

Authors:  Amber L Bahorik; Christina E Newhill; Shaun M Eack
Journal:  Schizophr Bull       Date:  2013-07-24       Impact factor: 9.306

3.  'False-positive' self-reported psychotic experiences in the general population: an investigation of outcome, predictive factors and clinical relevance.

Authors:  Y van der Steen; I Myin-Germeys; M van Nierop; M Ten Have; R de Graaf; S van Dorsselaer; J van Os; R van Winkel
Journal:  Epidemiol Psychiatr Sci       Date:  2018-04-16       Impact factor: 6.892

4.  Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization.

Authors:  Amber L Bahorik; Christina E Newhill; Shaun M Eack
Journal:  Addiction       Date:  2013-03-28       Impact factor: 6.526

5.  Childhood Maltreatment and Young Adulthood Hallucinations, Delusional Experiences, and Psychosis: A Longitudinal Study.

Authors:  Amanuel Alemu Abajobir; Steve Kisely; James G Scott; Gail Williams; Alexandra Clavarino; Lane Strathearn; Jake Moses Najman
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

6.  The prevalence of substance use disorders and psychiatric disorders as a function of psychotic symptoms.

Authors:  William V Lechner; Jennifer Dahne; Kevin W Chen; Alison Pickover; Jessica M Richards; Stacey B Daughters; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2013-01-03       Impact factor: 4.492

7.  Subclinical psychosis syndromes in the general population: results from a large-scale epidemiological survey among residents of the canton of Zurich, Switzerland.

Authors:  W Rössler; V Ajdacic-Gross; H Haker; S Rodgers; M Müller; M P Hengartner
Journal:  Epidemiol Psychiatr Sci       Date:  2013-11-26       Impact factor: 6.892

8.  Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people.

Authors:  Cécile Henquet; Lydia Krabbendam; Janneke Spauwen; Charles Kaplan; Roselind Lieb; Hans-Ulrich Wittchen; Jim van Os
Journal:  BMJ       Date:  2004-12-01

9.  Cannabis use and the risk of developing a psychotic disorder.

Authors:  Wayne Hall; Louisa Degenhardt
Journal:  World Psychiatry       Date:  2008       Impact factor: 49.548

10.  Should burden of disease estimates include cannabis use as a risk factor for psychosis?

Authors:  Louisa Degenhardt; Wayne D Hall; Michael Lynskey; John McGrath; Jennifer McLaren; Bianca Calabria; Harvey Whiteford; Theo Vos
Journal:  PLoS Med       Date:  2009-09-29       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.